Literature DB >> 25423557

Validation of a nomogram for predicting the probability of carcinoma in patients with intraductal papillary mucinous neoplasm in 180 pancreatic resection patients at 3 high-volume centers.

Yasuhiro Shimizu1, Hiroki Yamaue, Hiroyuki Maguchi, Kenji Yamao, Seiko Hirono, Manabu Osanai, Susumu Hijioka, Yukihide Kanemitsu, Tsuyoshi Sano, Yoshiki Senda, Vikram Bhatia, Akio Yanagisawa.   

Abstract

OBJECTIVE: We previously published a nomogram for prediction of carcinoma in patients with intraductal papillary mucinous neoplasm (IPMN). The objective of the current study was to validate this nomogram in an external cohort of patients at multiple institutions.
METHODS: The clinical details of 180 patients with IPMN who underwent a pancreatic resection at 3 hospitals were collected. Four significant predictive factors (sex, lesion type, nodule height, and pancreatic juice cytology) were analyzed.
RESULTS: Of the 180 patients, 66 (36.7%) had a main pancreatic duct-type IPMN and 114 (63.3%) had a branch pancreatic duct-type IPMN. The final pathological diagnosis was benign IPMN in 95 (52.8%) patients and malignant IPMN in 85 (47.2%) patients. The area under the receiver operating characteristic curve for the model was 0.760. The area under the receiver operating characteristic curve of the IPMN nomogram for prediction of malignancy was 0.747 in main pancreatic duct-type IPMN and 0.752 in branch pancreatic duct-type IPMN. The sensitivity and specificity of the model were 80.0% and 57.9%, respectively, when the predictive probability of more than 10% was used to indicate the presence of carcinoma.
CONCLUSIONS: This nomogram for predicting the probability of carcinoma in patients with IPMN was accurate in an external validation patient cohort.

Entities:  

Mesh:

Year:  2015        PMID: 25423557     DOI: 10.1097/MPA.0000000000000269

Source DB:  PubMed          Journal:  Pancreas        ISSN: 0885-3177            Impact factor:   3.327


  16 in total

1.  Validation of the American Gastroenterological Association guidelines on management of intraductal papillary mucinous neoplasms: more than 5 years of follow-up.

Authors:  Koh Imbe; Naoyoshi Nagata; Yuya Hisada; Yusuke Takasaki; Katsunori Sekine; Saori Mishima; Akihito Kawazoe; Tsuyoshi Tajima; Takuro Shimbo; Mikio Yanase; Junichi Akiyama; Kazuma Fujimoto; Naomi Uemura
Journal:  Eur Radiol       Date:  2017-08-02       Impact factor: 5.315

Review 2.  The diagnosis and management of intraductal papillary mucinous neoplasms of the pancreas: has progress been made?

Authors:  Jenny Lim; Peter J Allen
Journal:  Updates Surg       Date:  2019-06-07

3.  Multi-institutional Validation Study of Pancreatic Cyst Fluid Protein Analysis for Prediction of High-risk Intraductal Papillary Mucinous Neoplasms of the Pancreas.

Authors:  Mohammad A Al Efishat; Marc A Attiyeh; Anne A Eaton; Mithat Gönen; Denise Prosser; Anna E Lokshin; Carlos Fernández-Del Castillo; Keith D Lillemoe; Cristina R Ferrone; Ilaria Pergolini; Mari Mino-Kenudson; Neda Rezaee; Marco Dal Molin; Matthew J Weiss; John L Cameron; Ralph H Hruban; Michael I D'Angelica; T Peter Kingham; Ronald P DeMatteo; William R Jarnagin; Christopher L Wolfgang; Peter J Allen
Journal:  Ann Surg       Date:  2018-08       Impact factor: 12.969

4.  Development and Validation of a Multi-institutional Preoperative Nomogram for Predicting Grade of Dysplasia in Intraductal Papillary Mucinous Neoplasms (IPMNs) of the Pancreas: A Report from The Pancreatic Surgery Consortium.

Authors:  Marc A Attiyeh; Carlos Fernández-Del Castillo; Mohammad Al Efishat; Anne A Eaton; Mithat Gönen; Ruqayyah Batts; Ilaria Pergolini; Neda Rezaee; Keith D Lillemoe; Cristina R Ferrone; Mari Mino-Kenudson; Matthew J Weiss; John L Cameron; Ralph H Hruban; Michael I D'Angelica; Ronald P DeMatteo; T Peter Kingham; William R Jarnagin; Christopher L Wolfgang; Peter J Allen
Journal:  Ann Surg       Date:  2018-01       Impact factor: 12.969

Review 5.  Imaging modalities for characterising focal pancreatic lesions.

Authors:  Lawrence Mj Best; Vishal Rawji; Stephen P Pereira; Brian R Davidson; Kurinchi Selvan Gurusamy
Journal:  Cochrane Database Syst Rev       Date:  2017-04-17

6.  Peak density of immature nerve cells occurs with high-grade dysplasia in intraductal papillary mucinous neoplasms of the pancreas.

Authors:  Vincent Quoc-Huy Trinh; Joseph Thomas Roland; Jahg Wong; Frank Revetta; Krutika Patel; Chanjuan Shi; Kathleen E DelGiorno; Bruce D Carter; Marcus Chuan Beng Tan
Journal:  J Pathol       Date:  2022-07-18       Impact factor: 9.883

7.  Nomogram for the diagnosis of suspected papillary thyroid carcinomas based on sonographic patterns: a retrospective study.

Authors:  Li Liang; Jinhui Xie; Shulan Li; Jie Yang; Dongdong Chen; Nan Wang; Zubang Zhou
Journal:  Gland Surg       Date:  2019-08

8.  Evaluation of the 2015 AGA guidelines on pancreatic cystic neoplasms in a large surgically confirmed multicenter cohort.

Authors:  Phillip S Ge; V Raman Muthusamy; Srinivas Gaddam; Diana-Marie Jaiyeola; Stephen Kim; Alireza Sedarat; Timothy R Donahue; Lindsay Hosford; Robert H Wilson; David P Grande; Rajesh N Keswani; Vladimir M Kushnir; Daniel Mullady; Steven A Edmundowicz; Dayna S Early; Srinadh Komanduri; Sachin Wani; Rabindra R Watson
Journal:  Endosc Int Open       Date:  2017-03

9.  Morphological differentiation and follow-up of pancreatic cystic neoplasms using endoscopic ultrasound.

Authors:  Susumu Hijioka; Kazuo Hara; Nobumasa Mizuno; Hiroshi Imaoka; Vikram Bhatia; Kenji Yamao
Journal:  Endosc Ultrasound       Date:  2015 Oct-Dec       Impact factor: 5.628

Review 10.  Comparison of guidelines for intraductal papillary mucinous neoplasm: What is the next step beyond the current guidelines?

Authors:  Masafumi Nakamura; Yoshihiro Miyasaka; Yoshihiko Sadakari; Kenjiro Date; Takao Ohtsuka
Journal:  Ann Gastroenterol Surg       Date:  2017-06-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.